Denoci 120 Denoci 120 contains Denosumab 120 mg, a monoclonal antibody used to protect bones in patients with certain cancers. It helps reduce bone destruction by blocking the activity of cells that break down bone tissue, lowering the risk of fractures and other serious bone-related complications. Denoci is administered by a healthcare professional as part of a comprehensive cancer treatment plan.